Similarly, existing researches also demonstrated that FBXO5 upregulation was critically correlated to the poor prognosis of esophageal squamous cell carcinoma (10), hepatocellular carcinoma (12), squamous cell lung carcinoma (23), and breast cancer (11, 24). This evidence concerns the gene FBXO5 and hepatocellular carcinoma.